Aspire Biopharma (ASBP) Debt to Equity (2021 - 2026)
Aspire Biopharma (ASBP) debt to equity from Mar 31, 2021 to Mar 31, 2026. The current Aspire Biopharma (ASBP) debt to equity is 38.76%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Aspire Biopharma (ASBP)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | -21.63% | -73.77% |
| 2024 | -82.47% | -161571.43% |
| 2023 | 0.05% | -100.00% |
| 2021 | Infinity% | N/A |
Comparison Aspire Biopharma (ASBP) debt to equity with competitors
Aspire Biopharma (ASBP) debt to equity is 38.76%.